A96.2 Crimean-Congo hemorrhagic fever
ICD-10 A96.2 is a billable code used to indicate a diagnosis of a96.2 crimean-congo hemorrhagic fever.
Crimean-Congo hemorrhagic fever (CCHF) is a viral disease caused by the Crimean-Congo hemorrhagic fever virus (CCHFV), which is transmitted primarily by ticks and occasionally through contact with infected animals or humans. The disease is characterized by a sudden onset of fever, myalgia, dizziness, and gastrointestinal symptoms, which can progress to severe hemorrhagic manifestations, including bleeding from mucosal surfaces and internal organs. The mortality rate can be high, ranging from 10% to 40%, depending on the outbreak and the healthcare setting. CCHF is endemic in parts of Africa, the Balkans, the Middle East, and Central Asia, and is considered a significant public health threat due to its potential for outbreaks and high fatality rates. Diagnosis is typically confirmed through serological tests or PCR assays. Travel history to endemic regions is crucial for diagnosis, as well as awareness of potential exposure to ticks or infected individuals.
Detailed travel history, exposure risks, and laboratory confirmation.
Patients presenting with fever and bleeding after travel to endemic areas.
Need for interdisciplinary collaboration for management and reporting.
Immediate assessment of symptoms, travel history, and potential exposure.
Acute presentation of fever and hemorrhagic symptoms in patients with recent travel.
Rapid identification and isolation protocols may be necessary.
Used for confirming CCHF diagnosis through PCR testing.
Document the need for testing based on clinical presentation and travel history.
Infectious disease specialists should ensure proper specimen handling.
Key symptoms include sudden onset of fever, myalgia, dizziness, gastrointestinal bleeding, and petechiae. Severe cases may lead to shock and multi-organ failure.
